Cost effectiveness of mass screening for coeliac disease is determined by time‐delay to diagnosis and quality of life on a gluten‐free diet

Abstract

Our model suggests that mass screening for coeliac disease of the young-adult general population is associated with improved QALYs and is a cost effectiveness strategy. Shortening of the time-delay to diagnosis by heightened awareness of health-care professionals may be a valid alternative to screening.